This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Impaired glucose tolerance (IGT)

Authoring team

This is a stage of impaired glucose regulation (Fasting plasma glucose < 7.0 mmol/l and OGTT 2-hour value >= 7.8 mmol/l but < 11.1 mmol/l). (1)

The risk of subsequent conversion to diabetes is about 4.7% per year in Caucasians and higher in some ethnic minority groups.

  • these people should be followed up annually to reassess glucose regulation and all other cardiovascular risk factors

In 2010, the worldwide prevalence of glucose intolerance was about 8% (2)

Complications of impaired glucose tolerance include:

  • cardiovascular disease - in middle aged men with glucose intolerance have double the risk of death from cardiovascular disease
  • study evidence has revealed an increased mortality risk associated with IGT (3)
    • impaired glucose tolerance was associated with an increased mortality risk (HR 1.5, 95% CI 1.1 to 2.0)

Reference:

  1. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27.
  2. Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes. 2015 Mar 15;6(2):296-303
  3. Barr EL et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).Circulation. 2007 Jul 10;116(2):151-7

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.